{
    "organizations": [],
    "uuid": "dfe58ebf802c0d584e18e8038a0a7162f2cd7005",
    "author": "Charley Grant",
    "url": "https://www.wsj.com/articles/abbvie-gives-more-juice-to-drug-rally-1517065200",
    "ord_in_thread": 0,
    "title": "AbbVie Gives More Juice to Drug Rally",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "The world’s hottest big drug company had good news for more than just its own shareholders. Investors in companies focused on hepatitis C treatments also had new reasons to celebrate.\nAbbVie shares rose 14% to record highs after reporting strong fourth-quarter results on Friday, and they have doubled over the past year. There was much for investors to admire. Fourth-quarter revenue from Humira, the world’s best-selling drug, grew by 14% from a year ago to $4.9 billion, boosted by higher volume and price increases. And AbbVie... To Read the Full Story Subscribe Sign In",
    "published": "2018-01-27T18:00:00.000+02:00",
    "crawled": "2018-01-27T21:27:35.001+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "world",
        "hottest",
        "big",
        "drug",
        "company",
        "good",
        "news",
        "shareholder",
        "investor",
        "company",
        "focused",
        "hepatitis",
        "c",
        "treatment",
        "also",
        "new",
        "reason",
        "celebrate",
        "abbvie",
        "share",
        "rose",
        "record",
        "high",
        "reporting",
        "strong",
        "result",
        "friday",
        "doubled",
        "past",
        "year",
        "much",
        "investor",
        "admire",
        "revenue",
        "humira",
        "world",
        "drug",
        "grew",
        "year",
        "ago",
        "billion",
        "boosted",
        "higher",
        "volume",
        "price",
        "increase",
        "abbvie",
        "read",
        "full",
        "story",
        "subscribe",
        "sign"
    ]
}